- Home
- GNTA vs RDZN Comparison
GNTA vs RDZN Comparison
Compare GNTA & RDZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNTA
- RDZN
- Stock Information
- Founded
- GNTA 2014
- RDZN 2015
- Country
- GNTA Italy
- RDZN United States
- Employees
- GNTA N/A
- RDZN N/A
- Industry
- GNTA Biotechnology: Biological Products (No Diagnostic Substances)
- RDZN Blank Checks
- Sector
- GNTA Health Care
- RDZN Finance
- Exchange
- GNTA Nasdaq
- RDZN Nasdaq
- Market Cap
- GNTA 96.0M
- RDZN 107.6M
- IPO Year
- GNTA 2021
- RDZN N/A
- Fundamental
- Price
- GNTA $3.98
- RDZN $2.02
- Analyst Decision
- GNTA Strong Buy
- RDZN Strong Buy
- Analyst Count
- GNTA 1
- RDZN 2
- Target Price
- GNTA $25.00
- RDZN $5.00
- AVG Volume (30 Days)
- GNTA 21.3K
- RDZN 850.9K
- Earning Date
- GNTA 01-01-0001
- RDZN 02-10-2025
- Dividend Yield
- GNTA N/A
- RDZN N/A
- EPS Growth
- GNTA N/A
- RDZN N/A
- EPS
- GNTA N/A
- RDZN N/A
- Revenue
- GNTA N/A
- RDZN $46,448,411.00
- Revenue This Year
- GNTA N/A
- RDZN $4.38
- Revenue Next Year
- GNTA N/A
- RDZN $61.53
- P/E Ratio
- GNTA N/A
- RDZN N/A
- Revenue Growth
- GNTA N/A
- RDZN 57.97
- 52 Week Low
- GNTA $2.20
- RDZN $0.71
- 52 Week High
- GNTA $7.28
- RDZN $7.17
- Technical
- Relative Strength Index (RSI)
- GNTA 34.55
- RDZN 48.45
- Support Level
- GNTA $3.51
- RDZN $1.41
- Resistance Level
- GNTA $5.45
- RDZN $1.62
- Average True Range (ATR)
- GNTA 0.55
- RDZN 0.29
- MACD
- GNTA -0.10
- RDZN -0.08
- Stochastic Oscillator
- GNTA 13.90
- RDZN 23.95
About GNTA Genenta Science S.p.A.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain, and TEMs -Immuno-Gene Therapy.
About RDZN Roadzen Inc.
Roadzen Inc is an insurance technology company on a mission to transform global auto insurance powered by advanced AI. Its clients comprise major insurers, fleets, and carmakers to small fleets, brokers, and insurance agents that use Roadzen's technology to build new products, sell insurance, process claims, and improve road safety. The company's work in telematics and computer vision has earned recognition as an AI innovator by publications such as Forbes, Fortune, and Financial Express.